Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calmodulin is a phospholipase C-beta interacting protein.

Jennifer S McCullar1, Shana A Larsen, Ryan A Millimaki

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, and the Molecular and Cellular Biology Program, Oregon State University, Corvallis, Oregon 97331, USA.

The Journal of Biological Chemistry
|June 25, 2003
PubMed
Summary

Calmodulin (CaM) directly interacts with Phospholipase C-beta 3 (PLC beta 3), modulating its activity in G protein-coupled signaling pathways. This interaction is crucial for regulating cellular responses, such as inositol phospholipid hydrolysis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Cocurricular Activities to ACPE Standard #3 Elements by Student-Reported Competencies.

American journal of pharmaceutical education·2025
Same author

Professional Student Education and Training During the COVID-19 Pandemic.

Applied biosafety : journal of the American Biological Safety Association·2023
Same author

Gene Expression Profiling of Skeletal Muscles.

Genes·2021
Same author

Enhancing Pharmacy Faculty Well-Being and Productivity While Reducing Burnout.

American journal of pharmaceutical education·2021
Same author

Mifepristone and PGF<sub>2</sub>α activate phosphatidylinositol hydrolysis in the ovine corpus luteum.

Prostaglandins & other lipid mediators·2021
Same author

A de novo substitution in BCL11B leads to loss of interaction with transcriptional complexes and craniosynostosis.

Human molecular genetics·2019

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • Phospholipase C-beta 3 (PLC beta 3) is a key enzyme in G protein-coupled receptor (GPCR) signaling pathways.
  • While activation of PLC beta 3 by G protein subunits is understood, other regulatory protein interactions remain largely unknown.
  • Identifying novel regulators of PLC beta 3 is essential for a comprehensive understanding of cellular signaling.

Purpose of the Study:

  • To identify novel proteins that interact with Phospholipase C-beta 3 (PLC beta 3).
  • To investigate the functional significance of the interaction between PLC beta 3 and calmodulin (CaM).
  • To determine if CaM directly modulates PLC beta 3 activity in cellular signaling.

Main Methods:

  • Yeast two-hybrid screening of a mouse brain cDNA library using the N-terminus of PLC beta 3.

Related Experiment Videos

  • In vitro pull-down assays and co-precipitation experiments to confirm protein interactions.
  • Pharmacological inhibition of CaM and CaM kinase II to assess the physiological role of CaM in PLC beta activity.

    • Main Results:

    • Calmodulin (CaM) was identified as a potential interacting protein with PLC beta 3.
    • Direct physical interaction between CaM and PLC beta 3 (and PLC beta 1) was confirmed through multiple biochemical assays.
    • CaM inhibitors significantly reduced M1-muscarinic receptor-stimulated inositol phospholipid hydrolysis, indicating a physiological role for CaM in PLC beta activity modulation.

    Conclusions:

    • Calmodulin (CaM) directly binds to Phospholipase C-beta 3 (PLC beta 3) and PLC beta 1 isoforms.
    • This interaction plays a physiological role in modulating PLC beta activity, particularly in response to receptor stimulation.
    • The findings reveal a novel regulatory mechanism for PLC beta enzymes, independent of CaM kinase II.